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Abstract
Background To address the long-term problems of bearing
surface wear and osteolysis associated with conventional
metal-polyethylene (M-PE) total hip arthroplasty (THA),
metal-metal(M-M),andceramic-ceramic(C-C)bearingshave
been introduced. These bearing surfaces are associated with
uniquerisksandbeneﬁtsandhighercosts.Howevertherelative
risksofthesethreebearingsinanolderpopulationisunknown.
Questions/purposes We compared the short-term risk of
complication and revision THA among Medicare patients
having a primary THA with metal-polyethylene (M-PE),
metal-metal (M-M), and ceramic-ceramic (C-C) bearings.
Methods We used the 2005 to 2007 100% Medicare
inpatient claim ﬁles to perform a matched cohort analysis in
three separate cohorts of THA patients (M-PE, M-M, and
C-C) who were matched by age, gender, and US census
region. Multivariate Cox proportional-hazards models were
constructed to compare complication and revision THA risk
among cohorts, adjusting for medical comorbidities, race,
socioeconomic status, and hospital factors.
Results After adjusting for patient and hospital factors,
M-M bearings were associated with a higher risk of peri-
prosthetic joint infection (hazard ratio, 3.03; conﬁdence
interval, 1.02–9.09) when compared with C-C bearings
(0.59% versus 0.32%, respectively). There were no other
differences among bearing cohorts in the adjusted risk of
revision THA or any other complication.
Conclusions The risk of short-term complication
(including dislocation) and revision THA were similar
among appropriately matched Medicare THA patients
regardless of bearing surface. Hard-on-hard THA bearings
are of questionable value in Medicare patients, given the
higher cost associated with their use and uncertain long-
term beneﬁts in older patients.
Level of Evidence Level II, prognostic study. See Guide-
lines for Authors for a complete description of levels of
evidence.
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THA is one of the most clinically successful and cost-
effective healthcare interventions. Numerous investigators
have reported improved function, reduced pain, and high
rates of implant survivorship at up to 20 years’ followup
[4, 29]. However, concerns about limitations in implant
longevity related to the osteolysis associated with metal-
on-polyethylene (M-PE) bearing surface wear have led
to innovation in tribology [10, 15, 16] and the introduction
of new THA bearing couples over the past decade.
In particular, second-generation hard-on-hard bearings,
including metal-on-metal (M-M) and ceramic-on-ceramic
(C-C), have been introduced into the US market based on
laboratory studies showing lower wear rates when com-
pared with M-PE bearings [9, 10, 15]. Lower wear rates
associated with hard-on-hard bearings are likely to have
the biggest impact on revision rates in younger, more
active patients, who are at higher risk for wear-related
failures [3, 12, 17, 18, 27]. The long-term beneﬁts of more
costly hard-on-hard bearings are less obvious in older
patients, who are at lower risk for wear-related failures.
However, a potential beneﬁt of M-M bearings is the ability
to use large diameter femoral heads, which theoretically
could result in a lower short-term risk of dislocation when
compared with M-PE bearings. This potential beneﬁt
could be particularly advantageous in older patients
who are reportedly at higher risk for THA dislocation
[5, 25, 28].
We previously evaluated the epidemiology of THA
bearings in the entire United States population [7]. How-
ever, that study employed a cross-sectional study design,
and due to the nature of the database used (the Nationwide
Inpatient Sample), we were unable to compare longitudinal
patient outcomes and differences in the risks of compli-
cation and revision THA among patients with different
THA bearings [7].
The purpose of this study was to compare the short-term
risk of complication and revision THA among Medicare
patients having a primary THA with M-PE, M-M, and C-C
THA bearings.
Patients and Methods
The 2005 to 2007 100% Medicare inpatient claim ﬁles
were used to perform a matched cohort analysis in three
separate cohorts of THA patients (M-PE, M-M, C-C).
Patients in each THA cohort were matched by age, gender,
and US census region to the comparison or ‘control’
cohort, using a three to one matching ratio. M-M hip
resurfacing arthroplasty procedures (which have a separate
ICD-9-CM procedure code) were excluded from the anal-
ysis. Each M-M patient and C-C patient (case) were
matched to three M-PE patients (control), while each C-C
patient (case) was matched to three M-M patients (control).
For each ‘case’ patient, the eligible pool of controls con-
sisted of those patients who were within 3 years in age of
the case patient and who were at least 65 years old. If more
eligible controls were available than the three required per
case, controls closest in age were selected ﬁrst. Eligible
controls were also of the same gender and resided in the
same US Census region. All cases and controls had to be
enrolled in both Part A and Part B of Medicare. Patients
who received their Medicare health beneﬁts through a
health maintenance organization were excluded because
their healthcare expenses were not submitted to the Centers
for Medicare and Medicaid Services (CMS) for payment
and, therefore, claims from these beneﬁciaries were not
available from the database.
Primary THA patients were identiﬁed using Interna-
tional Classiﬁcation of Diseases, 9th rev, Clinical
Modiﬁcation (ICD-9-CM) procedure code 81.51 from the
inpatient claims records and grouped into three bearing
cohorts based on their corresponding ICD-9-CM optional
procedure modiﬁer bearing codes (00.74 for M-PE, 00.75
for M-M, 00.76 for C-C). Using each patient’s unique
de-identiﬁed beneﬁciary ID, the patients were tracked
longitudinally with revision THA or selected complications
as end points. Revision surgery was identiﬁed using ICD-9-
CM procedure codes 00.70–00.73 and 81.53. The selected
complications included deep venous thrombosis (DVT),
dislocation, infection, and mechanical loosening. DVT was
identiﬁed using the ICD-9-CM diagnosis codes 451.1,
451.2, 451.81, 451.9, 453.1, 453.2, 453.4, 453.8, and 453.9,
while THA dislocation was identiﬁed using any occurrence
of ICD-9 diagnosis codes 718.35, 835, or 996.42. Infection
and mechanical loosening were identiﬁed using ICD-9
diagnosis codes 996.66 and 996.41, respectively.
An overall cohort of 36,423 THA patients with M-PE
bearings were identiﬁed, along with 17,789 THA patients
with M-M bearings and 2,835 THA patients with C-C
bearings, from which the matched cohorts were derived.
The mean age of all THA recipients included in the study
was 74.5 years (SD = 6.4 years).
Multivariate Cox proportional-hazards models were
constructed to compare complication and revision THA risk
among cohorts, adjusting for medical comorbidities, race,
socioeconomic status, and hospital factors. The Medicare
buy-in status was used as an identiﬁer of patients whose
Medicare premiums and deductibles were subsidized by the
state(eg,Medicaid)andwereusedasaproxyforthepatient’s
socioeconomic status. To account for the health status of
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123each patient, the Charlson comorbidity index was used as a
measure of comorbid illness [13]. For this analysis, the
Charlson index values were grouped into the following
previously validated categories: 0 (none), 1 to 2 (low), 3 to 4
(moderate), and 5 or more (high) [24].
Results
Among younger Medicare patients (aged 65–69 years),
M-M bearings accounted for 35% of THA bearings and
C-C bearings accounted for 8%. Among older Medicare
patients (older than 80 years), 69% of patients had M-PE
bearings (Fig. 1). Among female patients, 67% had M-PE
bearings, while 29% had M-M bearings, compared to male
patients, among whom 60% had M-PE and 35% had M-M
bearings (Fig. 2). The highest frequency of M-PE bearing
surface use was in the Northeast (72%), and the highest
frequency of M-M bearing usage was in the South (37%),
while C-C bearing usage was fairly consistent across the
four US census regions (4%–5%) (Fig. 3).
When comparing the unadjusted risk of complication
using the Kaplan-Meier method, M-M bearings showed an
apparent trend toward higher overall risk of DVT (Fig. 4)
and revision THA (Fig. 5) than C-C bearings. However,
these differences were not present after adjusting for other
covariates in these matched cohorts (Table 1). After con-
trolling for patient and hospital factors, M-M bearings were
associated with a higher risk of periprosthetic joint infec-
tion (hazard ratio, 3.03; conﬁdence interval, 1.02–9.09)
when compared with C-C bearings. There were no other
differences among cohorts in the adjusted risk of revision
THA or any other complication, including DVT, disloca-
tion, or mechanical loosening (Table 1).
Discussion
THA has become one of the most commonly performed
operations in Medicare patients, with over 160,000 primary
and revision THA procedures reported in Medicare patients
in 2007 [1]. Successful THA allows elderly patients who
suffer from disabling hip disease to regain their function
and maintain a more active, healthy lifestyle. Nevertheless,
increased utilization and rising costs have led to concerns
regarding the appropriateness of using ‘premium’, more
expensive implant technologies in Medicare patients. Hard-
on-hard bearings are associated with lower wear rates in
the laboratory setting [15, 20]. However, wear-related
failures, such as bearing surface wear, osteolysis, and
mechanical loosening, may be less of a concern among
Medicare patients when compared with younger, more
active patients who undergo primary THA [8]. Therefore,
the higher cost associated with hard-on-hard bearings may
Fig. 1 The bearing surface frequency in Medicare THA patients by
age is shown.
Fig. 2 The bearing surface frequency in Medicare THA patients by
gender is shown.
Fig. 3 The bearing surface frequency in Medicare THA patients by
US census region is shown.
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123not be justiﬁable in terms of improved patient outcomes
and lower reoperation rates in Medicare patients, unless
they are associated with fewer short-term complications,
such as dislocation. One example of a potential short-term
beneﬁt of M-M bearings that is often cited is the ability to
use large diameter femoral heads, which theoretically
could result in a lower risk of dislocation when compared
with M-PE bearings. We therefore compared the short-term
risks of complication and revision THA among Medicare
patients having a primary THA with M-PE, M-M, and C-C
THA bearings.
Our ﬁndings are limited by the use of an administrative
database, where bearing surface type is an optional
modiﬁer code that can be reported in conjunction with the
primary procedure code (primary or revision total hip
arthroplasty), which introduces a potential source of bias
into our study. However, this limitation is somewhat mit-
igated by the matched cohort study design, where patients
with known bearing types were matched by age, gender,
and U.S. census region. Second, other variables of interest
which may inﬂuence patient outcomes, including surgical
approach, surgeon experience, and implant design are not
accessible from administrative claims, and we were only
able to evaluate complications which are captured in
administrative claims data, such as DVT, dislocation,
infection, mechanical loosening, and revision surgery,
Fig. 4 This graph shows trends of higher
overall rates of DVT for M-M versus C-C
bearings (unadjusted). (T) = percentage of
patients without the complication (DVT) at the
given time points.
Fig. 5 This graph shows trends of higher
overall rates of revision for M-M versus C-C
bearings (unadjusted). (T) = percentage of
patients without the complication (revision) at
the given time points.
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Third, since the optional bearing surface modiﬁer admin-
istrative codes were not introduced until October, 2005, our
study was limited to outcomes and complications that
occurred within two years of the index procedure. How-
ever, the rationale for our study was that presumably the
reason for using alternative bearings in Medicare patients is
to reduce short-term complication rates (eg, dislocation),
rather than long-term complications (eg, wear/osteolysis),
which are more of a concern in younger patients than in
Medicare patients. Furthermore, the Australian hip registry
[2] and other reports in the literature [6, 11, 19, 22, 23, 26]
have raised concerns regarding higher than expected short-
term complication and revision rates in patients with hard-
on-hard bearings. Nevertheless, further study is necessary
to evaluate differences in long-term clinical outcomes and
revision rates as additional data becomes available.
We found the adjusted risk of short-term complication
and revision THA among Medicare THA patients was
similar, regardless of bearing surface, with the exception of
patients who had M-M bearings, who had a slightly higher
risk of periprosthetic joint infection than patients who had
C-C bearings. The reasons underlying the increased risk of
infection for M-M bearings compared with C-C bearings,
even after adjusting for medical comorbidities and hospital
factors, remain unclear. It is possible that some of these
patients may have been misdiagnosed as having a peri-
prosthetic joint infection when in fact they had a local soft
tissue inﬂammatory reaction related to the M-M articula-
tion [6, 11]. The ﬁndings in some patients with such
reactions mimic periprosthetic joint infection, as reported
previously by Mikhael et al. [22]. Although the higher risk
of infection in the M-M cohort compared with the C-C
cohort was signiﬁcant (Hazard Ratio 3.03, CI = 1.02 
9.09), the clinical importance of this difference is unclear,
especially given the relatively low incidence of infection
(0.59% versus 0.32%, respectively).
The relatively high incidence of M-M bearings reported
in the Medicare population is somewhat surprising, given
M-M bearings are thought by some to be primarily indi-
cated for younger, more active patients who are at higher
risk for bearing surface wear and osteolysis with M-PE
bearings [14, 17, 20]. However, one theoretical advantage
of M-M bearings in older patients is improved stability (eg,
lower risk of dislocation) due to the ability to use larger-
diameter femoral heads. Our data do not demonstrate an
advantage of M-M bearings in terms of lower short-term
risk of dislocation when compared with either M-PE or
C-C bearings. This could be related to the increasing trend
of using 32- and 36-mm heads in M-PE bearings, which
may be sufﬁcient to substantially reduce the risk for dis-
location. Although the database used in this study did not
include information about femoral head size, according to
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123industry sources [21], the proportion of femoral heads
implanted in the US sized 32 mm or greater has increased
from approximately 12% to 79% between 1998 and 2008.
In summary, we found Medicare THA patients with
hard-on-hard (M-M, C-C) bearings had a similar risk of
complications and revision THA compared to patients who
had M-PE bearings during the ﬁrst 2 years after primary
THA. These ﬁndings provide a basis for additional analy-
ses of the comparative effectiveness of THA bearing
surfaces in the Medicare population.
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